Page 4 - Giovanni Caforio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novartis hikes full-year guidance as Q1 results exceed estimates, shares pop

Novartis hikes full-year guidance as Q1 results exceed estimates, shares pop
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Giovanni caforioVahid karaahmetovicJoerg reinhardtBristol myers squibb

Novartis raises targets for 2024

Novartis has raised its annual targets for net sales growth to mid-single-digit to low-single-digit, and for core operating income growth to double-digit to mid-single-digit.The Swiss healthcare giant.

Bristol myers squibbGiovanni caforioExecutive chairmanJoerg reinhardt

Novartis lifts guidance after Q1 results beat forecasts

Novartis lifts guidance after Q1 results beat forecasts
rte.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rte.ie Daily Mail and Mail on Sunday newspapers.

Bristol myers squibbGiovanni caforioJoerg reinhardt

Novartis Surges After Forecast Boost Beats Expectations

Novartis Surges After Forecast Boost Beats Expectations
swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.

Harry kirschGiovanni caforioJoerg reinhardtPeter welfordBristol myers squibb coChief financial officer harry kirschChief executive officer vas narasimhanBristol myers squibbSwiss pharma giants plot different pathsNext blockbusters

Why Is Novartis Stock Trading Higher On Tuesday? - Novartis (NYSE:NVS)

Discover Novartis' Q1 EPS soars 17% to $1.80, surpassing estimates. Sales hit $11.83B, up 10%. Entresto sales surge 36%, Cosentyx up 25%. CEO Vas Narasimhan bullish on mid & long-term growth.

Joerg reinhardtGiovanni caforioBristol myers squibb coVas narasimhan